4. Gilai AN. Analysis of turns and amplitude. In: EMG in Computer-Aided Electromyography and Experts Systems, ed. by Degmedt J E. Amsterdam: Elsevier Science Publishers; 1989;143-160.
5.
5. Stark B, Abramov A, Attias D, et al. Extended intrathecal triple therapy for preventing CNS relapse in non very high risk childhood acute lymphoblastic leukemia treated with the Israeli studies INS-84 and89 (modified BFM-86). Philadelphia: Proceedings of the American Society of Clinical Oncology1996:367-367.
6.
6. Kohli M, Bennet RM. An association of polymyalgia rheumatica with myelodysplastic syndromes. J Rheumatol. 1994;21:1357-1359.
7.
7. Varadarajulu R, Narayanaswamy AS, Kasthuri AS. Neurological manifestations of malignant disease. J Assoc Physicians India. 1991;39:377-378.
8.
8. Solon AA, Gilbert CS, Meyer C. Myopathy as a paraneoplastic manifestation of renal carcinoma. Am J Med. 1994;97:491-492.
9.
9. Kormarnicki M, Rasinska M. Myopathy as a first symptom in Hodgkin's disease. Acta Hematol Pol. 1994;25:59-61.
10.
10. Ueyama H, Kumamoto T, Araki S. Circulating autoantibody to muscle protein in a patient with paraneoplastic myositis and colon cancer. Eur Neurol. 1992;32:281-284.